It may soon be possible to identify Group 4 medulloblastomas –t he most common malignant brain tumor in children — from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, could lead to the development of better-targeted cancer treating drugs, according to investigators.
Click here for original story, Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children
Source: ScienceDaily